Key players in the market are involved in different business strategies such as gaining product approval from regulatory authorities, in order to expand their product portfolio. For instance, in August 2018, Envoy Medical Corporation, a U.S.-based company, received U.S. Food and Drug Administration (USFDA) for Esteem Hearing Implant. It is the first and only active middle ear implant to receive magnetic resonance (MR)-labeling for both 1.5 and 3.0 T scanning.
Major companies in the market are focused on different business strategies such as gaining product approval from regulatory authorities, in order to expand their product portfolio. For instance, in July 2019, MED-EL Corporation, a U.S.-based company, received the U.S. Food and Drug Administration for the company’s cochlear implant system for single-sided deafness.
Major companies in the market are involved in various business strategies such as research and development of novel products, in order provide effective solutions for middle ear implants and gain competitive edge in the market. For instance, in October 2018, Cochlear Limited announced the next phase in its long-term R&D program to develop implantable devices.